Latest Regulatory Progress News

Noxopharm is gearing up for a pivotal pre-IND meeting with the US FDA, enlisting global CRO Novotech to sharpen its regulatory approach for SOF-SKN, a drug targeting autoimmune skin diseases.

NeuRizer Ltd advanced its urea project with Reliance Industries payments and environmental submissions, despite ongoing ASX trading suspension and overdue financial reports.

Imricor Medical Systems has secured A$60 million through a placement to fund its US commercial rollout, regulatory approvals, and clinical programs, boosting its cash reserves to nearly A$103 million.

Energy Transition Minerals has released a JORC-compliant Mineral Resource Estimate for its Penouta tin-tantalum-niobium mine in Spain, reinforcing its strategic role in Europe's critical minerals supply chain and setting the stage for a project restart.

Sinowin Lithium, MRG Metals’ JV partner, will fund drilling at Corridor North in Mozambique, extending its investment beyond the 2 billion tonne Corridor Central and South projects targeting 2027 production and a ramp-up to 800,000 tonnes per annum.

RareX Limited has advanced its rare earths ambitions by securing a key mining lease at Cummins Range, appointing a strategic board member, and raising $5 million to fund exploration and development.

Alterity Therapeutics secures FDA backing on key Phase 3 elements for ATH434 in Multiple System Atrophy, bolstered by fresh Phase 2 data showing slowed disease progression and strategic leadership hires.

ReNerve Limited reports a 79% jump in quarterly sales, secures key Asia-Pacific approvals, and progresses its nerve repair pipeline with the NervAlign Nerve Guide Matrix entering Stage 3 development.

Maronan Metals secured Mineral Development Licence 2028, unlocking underground exploration, while metallurgical tests showed gold recoveries up to 88% and copper recoveries exceeding 96%. The company expanded its drilling program and bolstered leadership amid steady progress toward mine development.

Optiscan Imaging has submitted its FDA dossier for InSpecta®, marking a crucial step toward US veterinary market entry, while progressing clinical studies for InVue® and InForm® ahead of further FDA submissions in 2026.

Jade Gas Holdings has completed its appraisal program at the Tavan Tolgoi coal bed methane project, preparing to lodge its maiden gas reserve booking and advance development plans backed by fresh capital.

CurveBeam AI reported stable device orders but faces regulatory delays for FDA and China clearances, while securing a A$4 million investment from WEGO Orthopaedics and advancing clinical collaborations with robotic surgery systems.